ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,538,201 | -21.5% | 940,763 | +1.5% | 0.07% | -18.1% |
| Q2 2023 | $42,745,765 | +17.7% | 926,637 | +2.3% | 0.08% | +7.8% |
| Q1 2023 | $36,311,553 | +133.7% | 905,525 | +170.0% | 0.08% | +120.0% |
| Q4 2022 | $15,540,240 | +365.0% | 335,425 | +315.6% | 0.04% | +400.0% |
| Q3 2022 | $3,342,000 | -84.1% | 80,714 | -77.0% | 0.01% | -83.7% |
| Q2 2022 | $20,979,000 | -25.1% | 351,650 | -8.8% | 0.04% | -18.9% |
| Q1 2022 | $27,993,000 | +42.1% | 385,453 | +64.6% | 0.05% | +47.2% |
| Q4 2021 | $19,697,000 | +629.5% | 234,230 | +682.3% | 0.04% | +227.3% |
| Q3 2021 | $2,700,000 | -20.3% | 29,942 | -15.7% | 0.01% | -26.7% |
| Q2 2021 | $3,388,000 | -5.9% | 35,529 | +36.6% | 0.02% | -25.0% |
| Q4 2020 | $3,601,000 | +8.2% | 26,014 | -12.3% | 0.02% | -35.5% |
| Q4 2015 | $3,327,000 | -53.3% | 29,656 | -59.9% | 0.03% | -64.8% |
| Q3 2015 | $7,126,000 | +16.1% | 73,993 | +23.4% | 0.09% | +10.0% |
| Q2 2015 | $6,138,000 | -19.4% | 59,949 | -51.1% | 0.08% | -19.2% |
| Q1 2015 | $7,613,000 | – | 122,613 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |